You are viewing the site in preview mode

Skip to main content
Image 1 | Orphanet Journal of Rare Diseases

Image 1

From: The wide phenotypic spectrum of thiamine metabolism dysfunction syndrome 5 and its treatment

Image 1

Thiamine pathways: (A) Thiamine undergoes phosphorylation to produce thiamine pyrophosphate (TPP) through the action of thiamine pyrophosphokinase 1 (hTPK1). Further phosphorylation by mitochondrial thiamine triphosphosphate synthase results in thiamine triphosphate (TTP). Thiamine can be dephosphorylated to thiamine monophosphate (TMP) and thiamine by thiamine phosphatase. (B) The absorption of thiamine in the small intestine and its entry into cells involve transporters encoded by SLC19A2/SLC19A3. Inside cells, thiamine is pyrophosphorylated to its active form (TPP) by hTPK1. TPP serves as a cofactor for three dehydrogenases in mitochondria: (1) pyruvate dehydrogenase complex (PDHC), (2) branched-chain alfa-keto acid dehydrogenase (BCKDH), and (3) alpha-ketoglutarate dehydrogenase (α-KGDH). Outside of mitochondria, TPP functions as a cofactor for Transketolase and 2-hydroxyacyl-CoA Lyase 1 (HACL1)

Back to article page